SOURCE: Biodel, Inc.

Biodel, Inc.

March 04, 2015 08:00 ET

Biodel to Present at the 27th Annual ROTH Conference

DANBURY, CT--(Marketwired - March 04, 2015) - Biodel Inc. (NASDAQ: BIOD) management will be presenting an overview of the Company's technologies, development programs, and outlook at the 27th Annual ROTH Conference being held at The Ritz Carlton from March 8-11, 2015. Interested parties can access a link to a live webcast of the presentation from the News & Events section of the Biodel website, The corporate presentation of the Company will take place on Tuesday, March 10, 2015 at 8:30 a.m. PT. A live and archived webcast of the presentation will be accessible on the Biodel website at under "Webcasts" in the "News & Events" section.

About Biodel Inc. 
Biodel Inc. is a specialty biopharmaceutical company focused on the development and commercialization of innovative treatments for diabetes that may be safer, more effective and more convenient for patients. Biodel's product candidates are developed by applying proprietary technologies to existing drugs in order to improve their therapeutic profiles. More information about Biodel is available at


Contact Information

  • John Graziano
    +1 (646) 378 2942